Tradestie Institutional Equity Comparison Engine

AVBP vs ANNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ANNX Overall Edge

ANNX Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Annexon, Inc. Common Stock (ANNX) driven by superior Growth & Margin, Momentum & Technical while AVBP counters with relative strength in Options & Structure. Fundamentally, AVBP trades at N/M Forward P/E with -3620.0% operating margin (+0.0% YoY revenue) versus ANNX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AVBP sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AVBP N/M vs ANNX N/M Fwd P/E
Growth & Margin Winner ANNX
Op Margin -3620.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ANNX
1Y -48.3% vs +28.0% ยท 52W Pos 1% vs 18%
Options & Structure Winner AVBP
BREAKDOWN (16th %ile IV) vs BREAKDOWN (100th %ile IV)
AVBP NASDAQ
ArriVent BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$10.69
-7.53% 1D
Market Cap $672.9M
1M Return -40.41%
1Y Return -48.33%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 25.0 Fund 49.0 Flow 68.0 Mom 59.0
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.47
-2.8% 1D
Market Cap $747.8M
1M Return -13.47%
1Y Return +28.04%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 37.0 Fund 55.0 Flow 72.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVBP -48.33% ANNX +28.04% Spread: +76.37 pp (ANNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVBP TTM Op. Margin: -3620.0% ANNX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVBP vs ANNX. Trailing 12-month operating profitability (AVBP -3620.0% vs ANNX 0.0%) and valuation multiples (AVBP N/M vs ANNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVBP (1) vs ANNX (5)
Institutional Metric AVBP ANNX Criterion Row Winner
Market Capitalization Scale $672.9M $747.8M Larger Scale ANNX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability -3620.0% 0.0% Higher Margin ANNX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -48.7% -130.8% Higher ROE AVBP
52-Week Range Position Momentum 1% ($10โ€“$36) 18% ($3โ€“$7) Stronger Trend ANNX
Beta / 30D Volatility Risk Regime 1.35ฮฒ ยท 128% Vol 1.70ฮฒ ยท 63% Vol Lower Realized Risk ANNX
Unified Institutional Score Composite Signal 42.8 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite ANNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVBP vs ANNX Buy Guide
AVBP BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live AVBP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANNX BREAKDOWN
88d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVBP nor ANNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.